IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces an Investigation of Claims Against Valeant Pharmaceuticals International, Inc. on Behalf of Investors

Go back to IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces an Investigation of Claims Against Valeant Pharmaceuticals International, Inc. on Behalf of Investors

Icahn Wishes He Was Short Valeant (VRX) Stock - CNBC

October 21, 2015 12:42 PM EDT

Carl Icahn said Valeant Pharma (NYSE: VRX) is 'prime example' of inversion, according to an interview on CNBC today. Icahn also noted that he doesn't have a long position in the stock, but wishes he had a short position.

... More